EMERYVILLE, Calif., Sept. 12,
2024 /PRNewswire/ -- Eko Health, a pioneer in
applying artificial intelligence (AI) for early detection of heart
and lung diseases, today announced the appointment of Brent D. Lang, former Chairman and CEO of Vocera
Communications, to its Board of Directors.
Lang brings over three decades of healthcare and technology
experience, having led Vocera through rapid growth, a successful
IPO, and its $3 billion acquisition
by Stryker (NYSE: SYK). His strategic vision and proven leadership
will guide Eko as it continues to innovate and expand its platform
for early detection of heart and lung diseases for patients
worldwide.
"Brent's wealth of experience in healthcare technology and
company building, combined with a deep commitment to improving
patient outcomes, makes him the perfect partner for Eko as we
continue to help clinicians diagnose cardiopulmonary diseases
earlier and with greater accuracy," said Connor Landgraf, CEO of Eko Health. "We are
thrilled to welcome him to our Board."
Lang's appointment follows significant milestones for Eko,
including surpassing 500,000 healthcare providers on the platform,
completing a $41 million Series D,
and receiving FDA clearance for the first AI algorithm to aid heart
failure detection during routine exams.
"It's an honor to join Eko's Board at such a growth inflection
point for the company," said Lang. "Eko's technology is
revolutionizing the way clinicians detect and manage heart and lung
diseases, and I look forward to working with the team to ensure the
life-saving platform reaches millions of patients and providers
around the world in the coming years."
Beyond his distinguished career in healthcare, Lang is also an
Olympic gold medalist, having competed with the 1988 USA Men's
Swimming team. He continues to support athletes as an independent
director and treasurer for the USA
Gymnastics Board of Directors. Lang holds an MBA from the Stanford
Graduate School of Business and a bachelor's degree in industrial
and operations engineering from the University
of Michigan.
About Eko Health
Eko Health is a leading digital health company advancing how
healthcare professionals detect and monitor heart and lung disease
with its portfolio of digital stethoscopes, patient and provider
software, and AI-powered analysis. Its FDA-cleared platform, used
by over 500,000 healthcare professionals worldwide, allows them to
detect earlier and with higher accuracy, diagnose with more
confidence, manage treatment effectively, and ultimately give their
patients the best care possible. Eko Health is headquartered in
Emeryville, California, with over
$165 million in funding from ARTIS
Ventures, DigiTx Partners, Double Point Ventures, EDBI, Highland
Capital Partners, LG Technology Ventures, Mayo Clinic, Morningside
Technology Ventures Limited, NTTVC, Questa Capital, and others.
Media Contact
Sam Moore
sam.moore@ekohealth.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/eko-health-announces-appointment-of-brent-lang-former-ceo-of-vocera-to-board-of-directors-302246273.html
SOURCE Eko Health